SlideShare uma empresa Scribd logo
1 de 12
Baixar para ler offline
Farzana Sultana
BPH 04806682
Razia Sultana Riza
BPH 04806709
Tahmina
BPH 04806703
Sumona Alam
BPH 04806689
Rozi Hasan
BPH 04806767
Nazmus Sakib
BPH 04806686
Naproxen & esomeprazole
 Modified-release tablet containing enteric-coated (gastro-
resistant) naproxen and film-coated esomeprazole.
 Oval, yellow tablet marked '500/20' or ‘375/20' in black
ink.
Naproxen & esomeprazole
Composition
Composition
Justification
Justification of use Ingredients
API Naproxen & Esomeprazole
Polymer Hypromelloses, Ethylcelluloses, Opadry Clear,
HPMC K15M Premium CR
Plasticizer Tryethyl Citrate, Opadry Clear
Disintegrant Croscarmellose sodium
Binder Povidone (PVP K90), Povidone (PVP K30)
Filler Lactose monohydrate
Solvent lsopropyl alcohol, Methylene chloride, Methanol,
Water
Lubricant Macrogol PEG 400, Magnesium stearate
Antiadherent Magnesium stearate
Surfactant Poloxamer 188 (Lutrol P68)
Colorant Opadry Brown 02B86964
Printing Ink Hypromellose,Iron oxide black (E172), Propylene
glycol.
Manufacturing Process
1.Naproxen and croscarmellose sodium (first quantity)
are mixed and granulated with a solution of povidone
in water, in a fluid bed processor with top spray.
Granules are dried to a LOD less than 2% w/w.
2. Croscarmellose sodium (second quantity) is added
and blended for 5 minutes.
3. Magnesium stearate is added and blended for 5 minutes.
4. The mixture is compressed into tablets.
5. Ethyl cellulose, HPMC, and triethyl citrate are
dispersed in a mixture of isopropyl alcohol and
methylene chloride (1:1 volume ratio).
Manufacturing Process
6. The dispersion is coated onto tablets to
produce a 8-9% weight gain, after drying.
7. Subcoating ingredients are mixed to form
a suspension and coated onto the tablets, then
the tablets are dried.
8. Drug loading ingredients are mixed to
form a dispersion and coated onto subcoated tablets by pan coating,
then the tablets are dried.
9. Drug layered tablets are coated with a
mixture of the protective coating ingredients,
and dried.
Mode of action : This tablet has a sequential-delivery
tablet formulation combining an immediate release
esomeprazole magnesium layer and an enteric coated
delayed-release naproxen core. As a result, esomeprazole is
released in the stomach prior to the dissolution of naproxen
in the small intestine. The enteric coating prevents
naproxen release at pH levels below 5 providing protection
against possible local gastric toxicity of naproxen.
Dosage
The adult dosage is one tablet twice daily. The tablets
should be swallowed whole with water, and not split,
chewed or crushed.Unlike the administration directions for
most NSAIDs, it is recommended that this tablets are taken
at least 30 minutes before food.
Use : Osteoarthritis, rheumatoid arthritis and ankylosing spondylitis
Side Effects :
 Indigestion ,impaired sense of taste
 Inflammation of sinuses
 Back pain, dizziness, cough,constipation
 Burning or discomfort of stomach, gas, headache
Contraindications:
 Hypersensitivity to the active substances or to any of the excipients
 Severe hepatic impairment
 Severe heart failure
 Severe renal impairment
 Active peptic ulceration
 Gastrointestinal bleeding, cerebrovascular bleeding or other
bleeding disorders
Naproxen & esomeprazole
Brand Name :
 DEMOVO 375
 DEMOVO 500
 VIMOVO
 DINOVO 375/20
 DINOVO 500/20
Naproxen & esomeprazole combination

Mais conteúdo relacionado

Mais procurados

Generic Moxifloxacin Hydrochloride Tablets (Moxif)
Generic Moxifloxacin Hydrochloride Tablets (Moxif) Generic Moxifloxacin Hydrochloride Tablets (Moxif)
Generic Moxifloxacin Hydrochloride Tablets (Moxif) Clearsky Pharmacy
 
Formulation and evaluation of effervescent tablets.pptx
Formulation and evaluation of effervescent tablets.pptxFormulation and evaluation of effervescent tablets.pptx
Formulation and evaluation of effervescent tablets.pptxParimal Hadge
 
Hexgabalin pharmaceutical marketing plan - case study
Hexgabalin  pharmaceutical marketing plan - case studyHexgabalin  pharmaceutical marketing plan - case study
Hexgabalin pharmaceutical marketing plan - case studyAbdelrhman Tantawy
 
Oral Films Development & Manufacturing in India - Current Scenario
Oral Films Development & Manufacturing in India - Current ScenarioOral Films Development & Manufacturing in India - Current Scenario
Oral Films Development & Manufacturing in India - Current ScenarioSridhar Rudravarapu
 
Evaluation of tablet by dev d
Evaluation of tablet by dev dEvaluation of tablet by dev d
Evaluation of tablet by dev dDev Singh
 
Feature, Advantage & Benefit of Cefixime and Cefuroxime
Feature, Advantage & Benefit of Cefixime and CefuroximeFeature, Advantage & Benefit of Cefixime and Cefuroxime
Feature, Advantage & Benefit of Cefixime and CefuroximeShuman Das
 
Tablet coating defects
Tablet coating defectsTablet coating defects
Tablet coating defectsbss3118
 
New launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brandNew launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brandMohammad Masum Chowdhury
 
selection of packaging material for parentrals
selection of packaging material for parentralsselection of packaging material for parentrals
selection of packaging material for parentralsNilesh Utpure
 
Propellants in-pharmaceutical-aerosols
Propellants in-pharmaceutical-aerosolsPropellants in-pharmaceutical-aerosols
Propellants in-pharmaceutical-aerosolsVIJAY SINGH
 
Esomeprazole marketing plan by mehedee
Esomeprazole marketing plan by mehedeeEsomeprazole marketing plan by mehedee
Esomeprazole marketing plan by mehedeeMehedee Hasan
 
Nimalox re-branding marketing plan
Nimalox re-branding marketing planNimalox re-branding marketing plan
Nimalox re-branding marketing planMahmoUd Nasa
 

Mais procurados (20)

Generic Moxifloxacin Hydrochloride Tablets (Moxif)
Generic Moxifloxacin Hydrochloride Tablets (Moxif) Generic Moxifloxacin Hydrochloride Tablets (Moxif)
Generic Moxifloxacin Hydrochloride Tablets (Moxif)
 
Formulation and evaluation of effervescent tablets.pptx
Formulation and evaluation of effervescent tablets.pptxFormulation and evaluation of effervescent tablets.pptx
Formulation and evaluation of effervescent tablets.pptx
 
Cefpodoxime
CefpodoximeCefpodoxime
Cefpodoxime
 
Diclofenac Injection BRAND PLAN
Diclofenac Injection BRAND PLANDiclofenac Injection BRAND PLAN
Diclofenac Injection BRAND PLAN
 
Losart (Losar
Losart (LosarLosart (Losar
Losart (Losar
 
Hexgabalin pharmaceutical marketing plan - case study
Hexgabalin  pharmaceutical marketing plan - case studyHexgabalin  pharmaceutical marketing plan - case study
Hexgabalin pharmaceutical marketing plan - case study
 
Preformulation studies
Preformulation studiesPreformulation studies
Preformulation studies
 
Oral Films Development & Manufacturing in India - Current Scenario
Oral Films Development & Manufacturing in India - Current ScenarioOral Films Development & Manufacturing in India - Current Scenario
Oral Films Development & Manufacturing in India - Current Scenario
 
Sustained release formulation 2012
Sustained release formulation 2012Sustained release formulation 2012
Sustained release formulation 2012
 
Evaluation of tablet by dev d
Evaluation of tablet by dev dEvaluation of tablet by dev d
Evaluation of tablet by dev d
 
Feature, Advantage & Benefit of Cefixime and Cefuroxime
Feature, Advantage & Benefit of Cefixime and CefuroximeFeature, Advantage & Benefit of Cefixime and Cefuroxime
Feature, Advantage & Benefit of Cefixime and Cefuroxime
 
Etizola brand plan
Etizola brand planEtizola brand plan
Etizola brand plan
 
Tablet coating defects
Tablet coating defectsTablet coating defects
Tablet coating defects
 
New launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brandNew launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brand
 
Ch 3 tablet industrial pharmacy
Ch 3 tablet industrial pharmacyCh 3 tablet industrial pharmacy
Ch 3 tablet industrial pharmacy
 
selection of packaging material for parentrals
selection of packaging material for parentralsselection of packaging material for parentrals
selection of packaging material for parentrals
 
Propellants in-pharmaceutical-aerosols
Propellants in-pharmaceutical-aerosolsPropellants in-pharmaceutical-aerosols
Propellants in-pharmaceutical-aerosols
 
Esomeprazole marketing plan by mehedee
Esomeprazole marketing plan by mehedeeEsomeprazole marketing plan by mehedee
Esomeprazole marketing plan by mehedee
 
pellets final
pellets finalpellets final
pellets final
 
Nimalox re-branding marketing plan
Nimalox re-branding marketing planNimalox re-branding marketing plan
Nimalox re-branding marketing plan
 

Semelhante a Naproxen & esomeprazole combination

Non Steroidal Anti-Inflammatory Drugs
Non Steroidal Anti-Inflammatory DrugsNon Steroidal Anti-Inflammatory Drugs
Non Steroidal Anti-Inflammatory DrugsHrishitaMajumder
 
Anticholinergics D.Pharm PC II
Anticholinergics D.Pharm PC IIAnticholinergics D.Pharm PC II
Anticholinergics D.Pharm PC IISowmiya Perinbaraj
 
DESIGN, PREPARATION, EVALUATION, COMPATIBILITY AND INVITRO STUDIES OF NAPROXE...
DESIGN, PREPARATION, EVALUATION, COMPATIBILITY AND INVITRO STUDIES OF NAPROXE...DESIGN, PREPARATION, EVALUATION, COMPATIBILITY AND INVITRO STUDIES OF NAPROXE...
DESIGN, PREPARATION, EVALUATION, COMPATIBILITY AND INVITRO STUDIES OF NAPROXE...Maksud Al- Hasan (Mahim)
 
How to reduce fever, pain and inflammation in toddlers?
How to reduce fever, pain and inflammation in toddlers?How to reduce fever, pain and inflammation in toddlers?
How to reduce fever, pain and inflammation in toddlers?avanlimedia
 
Nonsteroidal anti inflammatory drugs
Nonsteroidal anti inflammatory drugsNonsteroidal anti inflammatory drugs
Nonsteroidal anti inflammatory drugsDrAbhinandk
 
Nexpro (Esomeprazole Magnesium Tablets)
Nexpro (Esomeprazole Magnesium Tablets)Nexpro (Esomeprazole Magnesium Tablets)
Nexpro (Esomeprazole Magnesium Tablets)Clearsky Pharmacy
 
Organophosphorus_Poisoning_final.pptx
Organophosphorus_Poisoning_final.pptxOrganophosphorus_Poisoning_final.pptx
Organophosphorus_Poisoning_final.pptxbiplave karki
 
Anti Parkinson Disease | PDF | Pharmacology | Assignment
Anti Parkinson Disease | PDF | Pharmacology | Assignment Anti Parkinson Disease | PDF | Pharmacology | Assignment
Anti Parkinson Disease | PDF | Pharmacology | Assignment MrHotmaster1
 
Formulation and evaluation of fast dissolving tablet- by aryan and rajesh
Formulation and evaluation of fast dissolving tablet- by aryan and rajeshFormulation and evaluation of fast dissolving tablet- by aryan and rajesh
Formulation and evaluation of fast dissolving tablet- by aryan and rajeshSridhar Sri
 
Drugs used in neurological disorder
Drugs used in neurological disorderDrugs used in neurological disorder
Drugs used in neurological disorderAIIMS
 
drug book.docx
drug book.docxdrug book.docx
drug book.docxFaraBegum
 
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,ManikB. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,ManikImran Nur Manik
 

Semelhante a Naproxen & esomeprazole combination (20)

Non Steroidal Anti-Inflammatory Drugs
Non Steroidal Anti-Inflammatory DrugsNon Steroidal Anti-Inflammatory Drugs
Non Steroidal Anti-Inflammatory Drugs
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Anticholinergics D.Pharm PC II
Anticholinergics D.Pharm PC IIAnticholinergics D.Pharm PC II
Anticholinergics D.Pharm PC II
 
article_wjpr_1432986055-1
article_wjpr_1432986055-1article_wjpr_1432986055-1
article_wjpr_1432986055-1
 
DESIGN, PREPARATION, EVALUATION, COMPATIBILITY AND INVITRO STUDIES OF NAPROXE...
DESIGN, PREPARATION, EVALUATION, COMPATIBILITY AND INVITRO STUDIES OF NAPROXE...DESIGN, PREPARATION, EVALUATION, COMPATIBILITY AND INVITRO STUDIES OF NAPROXE...
DESIGN, PREPARATION, EVALUATION, COMPATIBILITY AND INVITRO STUDIES OF NAPROXE...
 
How to reduce fever, pain and inflammation in toddlers?
How to reduce fever, pain and inflammation in toddlers?How to reduce fever, pain and inflammation in toddlers?
How to reduce fever, pain and inflammation in toddlers?
 
Nonsteroidal anti inflammatory drugs
Nonsteroidal anti inflammatory drugsNonsteroidal anti inflammatory drugs
Nonsteroidal anti inflammatory drugs
 
9.epirazole
9.epirazole9.epirazole
9.epirazole
 
Nexpro (Esomeprazole Magnesium Tablets)
Nexpro (Esomeprazole Magnesium Tablets)Nexpro (Esomeprazole Magnesium Tablets)
Nexpro (Esomeprazole Magnesium Tablets)
 
Xenleta
XenletaXenleta
Xenleta
 
proton pump inhibitors PPT
proton pump inhibitors PPTproton pump inhibitors PPT
proton pump inhibitors PPT
 
Organophosphorus_Poisoning_final.pptx
Organophosphorus_Poisoning_final.pptxOrganophosphorus_Poisoning_final.pptx
Organophosphorus_Poisoning_final.pptx
 
Omeprazole
OmeprazoleOmeprazole
Omeprazole
 
GPPI,PDF.pdf
GPPI,PDF.pdfGPPI,PDF.pdf
GPPI,PDF.pdf
 
Anti Parkinson Disease | PDF | Pharmacology | Assignment
Anti Parkinson Disease | PDF | Pharmacology | Assignment Anti Parkinson Disease | PDF | Pharmacology | Assignment
Anti Parkinson Disease | PDF | Pharmacology | Assignment
 
Formulation and evaluation of fast dissolving tablet- by aryan and rajesh
Formulation and evaluation of fast dissolving tablet- by aryan and rajeshFormulation and evaluation of fast dissolving tablet- by aryan and rajesh
Formulation and evaluation of fast dissolving tablet- by aryan and rajesh
 
Drugs used in neurological disorder
Drugs used in neurological disorderDrugs used in neurological disorder
Drugs used in neurological disorder
 
Paracetamol.pptx
Paracetamol.pptxParacetamol.pptx
Paracetamol.pptx
 
drug book.docx
drug book.docxdrug book.docx
drug book.docx
 
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,ManikB. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
B. Pharm. (Honours) Part-III Practical, Medicinal Chemistry,Manik
 

Mais de Farzana Sultana

Industrial production of recombinant human insulin
Industrial production of recombinant human insulinIndustrial production of recombinant human insulin
Industrial production of recombinant human insulinFarzana Sultana
 
Common Diseases of the heart
Common Diseases of the heartCommon Diseases of the heart
Common Diseases of the heartFarzana Sultana
 
Drug design, discovery and development
Drug design, discovery and developmentDrug design, discovery and development
Drug design, discovery and developmentFarzana Sultana
 
Site specific drug delivery utilizing monoclonal antibodies
Site specific drug delivery utilizing monoclonal antibodiesSite specific drug delivery utilizing monoclonal antibodies
Site specific drug delivery utilizing monoclonal antibodiesFarzana Sultana
 
Advanced Drug delivery systems
Advanced Drug delivery systemsAdvanced Drug delivery systems
Advanced Drug delivery systemsFarzana Sultana
 
Diabetes mellitus overview and treatments
Diabetes mellitus overview and treatmentsDiabetes mellitus overview and treatments
Diabetes mellitus overview and treatmentsFarzana Sultana
 
Application of filtration process in pharmaceutical
Application of filtration process in pharmaceuticalApplication of filtration process in pharmaceutical
Application of filtration process in pharmaceuticalFarzana Sultana
 
Industrial hazards in pharmaceutical plant
Industrial hazards in pharmaceutical plantIndustrial hazards in pharmaceutical plant
Industrial hazards in pharmaceutical plantFarzana Sultana
 
Common Clinical disorders in elderly
Common Clinical disorders in elderlyCommon Clinical disorders in elderly
Common Clinical disorders in elderlyFarzana Sultana
 
Differences between Marketing concept and selling concept
Differences between Marketing concept and selling conceptDifferences between Marketing concept and selling concept
Differences between Marketing concept and selling conceptFarzana Sultana
 
Introduction of new generic
Introduction of new genericIntroduction of new generic
Introduction of new genericFarzana Sultana
 

Mais de Farzana Sultana (14)

Industrial production of recombinant human insulin
Industrial production of recombinant human insulinIndustrial production of recombinant human insulin
Industrial production of recombinant human insulin
 
Common Diseases of the heart
Common Diseases of the heartCommon Diseases of the heart
Common Diseases of the heart
 
Prodrug
ProdrugProdrug
Prodrug
 
Drug design, discovery and development
Drug design, discovery and developmentDrug design, discovery and development
Drug design, discovery and development
 
Site specific drug delivery utilizing monoclonal antibodies
Site specific drug delivery utilizing monoclonal antibodiesSite specific drug delivery utilizing monoclonal antibodies
Site specific drug delivery utilizing monoclonal antibodies
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Advanced Drug delivery systems
Advanced Drug delivery systemsAdvanced Drug delivery systems
Advanced Drug delivery systems
 
Diabetes mellitus overview and treatments
Diabetes mellitus overview and treatmentsDiabetes mellitus overview and treatments
Diabetes mellitus overview and treatments
 
Application of filtration process in pharmaceutical
Application of filtration process in pharmaceuticalApplication of filtration process in pharmaceutical
Application of filtration process in pharmaceutical
 
Anti depressant agents
Anti depressant agentsAnti depressant agents
Anti depressant agents
 
Industrial hazards in pharmaceutical plant
Industrial hazards in pharmaceutical plantIndustrial hazards in pharmaceutical plant
Industrial hazards in pharmaceutical plant
 
Common Clinical disorders in elderly
Common Clinical disorders in elderlyCommon Clinical disorders in elderly
Common Clinical disorders in elderly
 
Differences between Marketing concept and selling concept
Differences between Marketing concept and selling conceptDifferences between Marketing concept and selling concept
Differences between Marketing concept and selling concept
 
Introduction of new generic
Introduction of new genericIntroduction of new generic
Introduction of new generic
 

Último

CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 

Último (20)

CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 

Naproxen & esomeprazole combination

  • 1. Farzana Sultana BPH 04806682 Razia Sultana Riza BPH 04806709 Tahmina BPH 04806703 Sumona Alam BPH 04806689 Rozi Hasan BPH 04806767 Nazmus Sakib BPH 04806686
  • 2. Naproxen & esomeprazole  Modified-release tablet containing enteric-coated (gastro- resistant) naproxen and film-coated esomeprazole.  Oval, yellow tablet marked '500/20' or ‘375/20' in black ink.
  • 6. Justification Justification of use Ingredients API Naproxen & Esomeprazole Polymer Hypromelloses, Ethylcelluloses, Opadry Clear, HPMC K15M Premium CR Plasticizer Tryethyl Citrate, Opadry Clear Disintegrant Croscarmellose sodium Binder Povidone (PVP K90), Povidone (PVP K30) Filler Lactose monohydrate Solvent lsopropyl alcohol, Methylene chloride, Methanol, Water Lubricant Macrogol PEG 400, Magnesium stearate Antiadherent Magnesium stearate Surfactant Poloxamer 188 (Lutrol P68) Colorant Opadry Brown 02B86964 Printing Ink Hypromellose,Iron oxide black (E172), Propylene glycol.
  • 7. Manufacturing Process 1.Naproxen and croscarmellose sodium (first quantity) are mixed and granulated with a solution of povidone in water, in a fluid bed processor with top spray. Granules are dried to a LOD less than 2% w/w. 2. Croscarmellose sodium (second quantity) is added and blended for 5 minutes. 3. Magnesium stearate is added and blended for 5 minutes. 4. The mixture is compressed into tablets. 5. Ethyl cellulose, HPMC, and triethyl citrate are dispersed in a mixture of isopropyl alcohol and methylene chloride (1:1 volume ratio).
  • 8. Manufacturing Process 6. The dispersion is coated onto tablets to produce a 8-9% weight gain, after drying. 7. Subcoating ingredients are mixed to form a suspension and coated onto the tablets, then the tablets are dried. 8. Drug loading ingredients are mixed to form a dispersion and coated onto subcoated tablets by pan coating, then the tablets are dried. 9. Drug layered tablets are coated with a mixture of the protective coating ingredients, and dried.
  • 9. Mode of action : This tablet has a sequential-delivery tablet formulation combining an immediate release esomeprazole magnesium layer and an enteric coated delayed-release naproxen core. As a result, esomeprazole is released in the stomach prior to the dissolution of naproxen in the small intestine. The enteric coating prevents naproxen release at pH levels below 5 providing protection against possible local gastric toxicity of naproxen. Dosage The adult dosage is one tablet twice daily. The tablets should be swallowed whole with water, and not split, chewed or crushed.Unlike the administration directions for most NSAIDs, it is recommended that this tablets are taken at least 30 minutes before food.
  • 10. Use : Osteoarthritis, rheumatoid arthritis and ankylosing spondylitis Side Effects :  Indigestion ,impaired sense of taste  Inflammation of sinuses  Back pain, dizziness, cough,constipation  Burning or discomfort of stomach, gas, headache Contraindications:  Hypersensitivity to the active substances or to any of the excipients  Severe hepatic impairment  Severe heart failure  Severe renal impairment  Active peptic ulceration  Gastrointestinal bleeding, cerebrovascular bleeding or other bleeding disorders
  • 11. Naproxen & esomeprazole Brand Name :  DEMOVO 375  DEMOVO 500  VIMOVO  DINOVO 375/20  DINOVO 500/20